Sustainable KLH Technologies for Growing Markets

PRESS RELEASES

Stellar Biotechnologies Presents at Annual 2013 National Science Foundation Conference
May 28, 2013
Stellar Biotechnologies, Inc. (“Stellar” or the “Company”) (OTCQB: SBOTF)...  Read More
Stellar Biotechnologies To Present At The Second Annual Marcum Llp Microcap Conference
May 21, 2013
Stellar Biotechnologies, Inc. (SBOTF: OTCQB) (KLH: TSX-V) announced today...  Read More
Subscribe to RSS

Sedar Filing  Edgar Filing

Our platform is Stellar KLH™. Our commitment is to excellence in targeted immune therapies and immunodiagnostics.  

Stellar Biotechnologies is the world leader in sustainable manufacture of Keyhole Limpet Hemocyanin (KLH). We serve the growing demand for this essential molecule and we are focused on applying our expertise to targeted therapeutics and immunodiagnostics. Read more

KLH is an important immune-stimulating protein, highly valued in wide-ranging therapeutic and diagnostic markets. Stellar Biotechnologies revolutionized the KLH industry, turning this vital, natural protein into a renewable, quality resource. Read about Stellar KLH™